Skip to main content
. 2008 Oct 3;8:284. doi: 10.1186/1471-2407-8-284

Table 5.

Methylation status of the TGFBI promoter in prostate cancer prostatectomy specimens with or without locoregional invasiveness

Locoregional invasiveness status of prostatectomy specimen Number of methylated CpG sites

0 5–10 16
Positive (n = 18) 2 (11.1%) 9 (50.0%) 7 (38.9%)*
Negative (n = 31) 7 (22.6%) 18 (58.1%) 6 (19.4%)*

*P < 0.05